Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2013 1
2014 1
2016 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC).
Parikh PM, Biswas G, Dhamne NA, Deshmukh CD, Limaye S, Singh A, Malhotra H, Maniar VP, Kapur BN, Sripada PVSS, Talreja VT, Patil P, Agre SV, Bhat AD, Nayak PP, Seshachalam A, Dhabhar BN, Sharma A, Bhatt NN, Das PK, Sharma A, Kanakasetty GB, Advani SH. Parikh PM, et al. Among authors: deshmukh cd. South Asian J Cancer. 2024 Oct 16;14(1):90-102. doi: 10.1055/s-0044-1791783. eCollection 2025 Jan. South Asian J Cancer. 2024. PMID: 40124157 Free PMC article.
Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study.
Jain MM, Gupte SU, Patil SG, Pathak AB, Deshmukh CD, Bhatt N, Haritha C, Govind Babu K, Bondarde SA, Digumarti R, Bajpai J, Kumar R, Bakshi AV, Bhattacharya GS, Patil P, Subramanian S, Vaid AK, Desai CJ, Khopade A, Chimote G, Bapsy PP, Bhowmik S. Jain MM, et al. Among authors: deshmukh cd. Breast Cancer Res Treat. 2016 Feb;156(1):125-34. doi: 10.1007/s10549-016-3736-9. Epub 2016 Mar 3. Breast Cancer Res Treat. 2016. PMID: 26941199 Free PMC article. Clinical Trial.
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.
Awan FT, Hillmen P, Hellmann A, Robak T, Hughes SG, Trone D, Shannon M, Flinn IW, Byrd JC; LUCID trial investigators. Awan FT, et al. Br J Haematol. 2014 Nov;167(4):466-77. doi: 10.1111/bjh.13061. Epub 2014 Aug 8. Br J Haematol. 2014. PMID: 25130401 Free article. Clinical Trial.